NCT05084430 2026-01-22Study of Pembrolizumab and M032 (NSC 733972)University of Alabama at BirminghamPhase 1/2 Recruiting28 enrolled
NCT05039281 2025-12-19Atezolizumab and Cabozantinib for the Treatment of Recurrent GlioblastomaM.D. Anderson Cancer CenterPhase 1/2 Recruiting6 enrolled